Prunella Blinman

1.2k total citations
53 papers, 787 citations indexed

About

Prunella Blinman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Prunella Blinman has authored 53 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Prunella Blinman's work include Lung Cancer Treatments and Mutations (12 papers), Cancer survivorship and care (11 papers) and Colorectal Cancer Treatments and Studies (9 papers). Prunella Blinman is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Cancer survivorship and care (11 papers) and Colorectal Cancer Treatments and Studies (9 papers). Prunella Blinman collaborates with scholars based in Australia, United States and United Kingdom. Prunella Blinman's co-authors include Martin R. Stockler, Haryana M. Dhillon, Janette L. Vardy, Belinda E. Kiely, Chris Brown, Rosalie Viney, Richard Norman, Madeleine King, V. Duric and Sue‐Anne McLachlan and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Prunella Blinman

52 papers receiving 784 citations

Peers

Prunella Blinman
Melissa Accordino United States
Nina N. Sanford United States
Randa Sifri United States
Belinda E. Kiely Australia
Clarissa Mathias Brazil
Corina van den Hurk Netherlands
J. Bernhard Switzerland
Jacobo Rogado Spain
Natalie Fitzgerald Canada
Inge R. Konings Netherlands
Melissa Accordino United States
Prunella Blinman
Citations per year, relative to Prunella Blinman Prunella Blinman (= 1×) peers Melissa Accordino

Countries citing papers authored by Prunella Blinman

Since Specialization
Citations

This map shows the geographic impact of Prunella Blinman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prunella Blinman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prunella Blinman more than expected).

Fields of papers citing papers by Prunella Blinman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prunella Blinman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prunella Blinman. The network helps show where Prunella Blinman may publish in the future.

Co-authorship network of co-authors of Prunella Blinman

This figure shows the co-authorship network connecting the top 25 collaborators of Prunella Blinman. A scholar is included among the top collaborators of Prunella Blinman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prunella Blinman. Prunella Blinman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Galettis, Peter, et al.. (2023). Comparison of capecitabine concentrations determined by microsampling versus plasma concentrations for therapeutic drug monitoring: a pilot study. Journal of Pharmacy and Pharmacology. 76(2). 86–92. 1 indexed citations
2.
Dhillon, Haryana M., et al.. (2023). Scanxiety Conversations on Twitter: Observational Study. JMIR Cancer. 9. e43609–e43609. 2 indexed citations
3.
Laidsaar‐Powell, Rebekah, Jane Young, Daniel Steffens, et al.. (2022). Work: saviour or struggle? A qualitative study examining employment and finances in colorectal cancer survivors living with advanced cancer. Supportive Care in Cancer. 30(11). 9057–9069. 13 indexed citations
4.
Blinman, Prunella, et al.. (2022). The utility of surveillance CT scans in a cohort of survivors of colorectal cancer. Journal of Cancer Survivorship. 17(4). 1202–1210. 1 indexed citations
5.
Liang, Roger J., et al.. (2021). Scanxiety: a scoping review about scan-associated anxiety. BMJ Open. 11(5). e043215–e043215. 49 indexed citations
6.
Kiely, Belinda E., et al.. (2021). Prevalence and severity of scanxiety in people with advanced cancers: a multicentre survey. Supportive Care in Cancer. 30(1). 511–519. 20 indexed citations
7.
Roberts, Tara L., Wei Chua, Therese M. Becker, et al.. (2021). Plasma pre-treatment T790M relative allelic frequency in patients with advanced EGFR-mutated non-small cell lung cancer predicts treatment response to subsequent-line osimertinib. Translational Lung Cancer Research. 10(4). 1623–1634. 6 indexed citations
8.
Blinman, Prunella, et al.. (2020). Factors associated with fear of cancer recurrence in breast and colorectal cancer survivors: A cross‐sectional study of cancer survivors. Asia-Pacific Journal of Clinical Oncology. 17(3). 222–229. 15 indexed citations
9.
Blinman, Prunella, Andrew Martin, Michael Jefford, et al.. (2020). Patients’ Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer. JNCI Cancer Spectrum. 5(1). 4 indexed citations
10.
Dhillon, Haryana M., et al.. (2020). Why do delays to diagnosis and treatment of lung cancer occur? A mixed methods study of insights from Australian clinicians. Asia-Pacific Journal of Clinical Oncology. 17(2). e77–e86. 3 indexed citations
11.
Blinman, Prunella, et al.. (2018). Understanding Immune Tolerance of Cancer: Re‐Purposing Insights from Fetal Allografts and Microbes. BioEssays. 40(8). e1800050–e1800050. 7 indexed citations
12.
Karapetis, Christos S., B. Stein, Bogda Koczwara, et al.. (2018). Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying. Internal Medicine Journal. 48(7). 774–779. 23 indexed citations
13.
14.
Blinman, Prunella, et al.. (2018). How long is too long? A scoping review of health system delays in lung cancer. European Respiratory Review. 27(149). 180045–180045. 57 indexed citations
15.
Blinman, Prunella, Andrew Martin, Shomik Sengupta, et al.. (2017). Patients’ preferences for adjuvant sorafenib after resection of renal cell carcinoma in the SORCE trial: what makes it worthwhile?. Annals of Oncology. 29(2). 370–376. 12 indexed citations
16.
Dhillon, Haryana M., Melanie L. Bell, Hidde P. van der Ploeg, et al.. (2017). Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: a randomized controlled trial. Annals of Oncology. 28(8). 1889–1897. 88 indexed citations
17.
Lawrence, Nicola Jane, Amelia Rodríguez Martín, Ian D. Davis, et al.. (2017). Predicted benefits of adjuvant sorafenib after nephrectomy for renal cell carcinoma (RCC) in SORCE: an international, placebo-controlled, randomised phase 3 trial. Annals of Oncology. 28. v310–v311. 1 indexed citations
18.
Blinman, Prunella, Brett Hughes, Catherine Crombie, et al.. (2015). Patients’ and doctors’ preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?. European Journal of Cancer. 51(12). 1529–1537. 23 indexed citations
19.
Blinman, Prunella, Madeleine King, Richard Norman, Rosalie Viney, & Martin R. Stockler. (2012). Preferences for cancer treatments: an overview of methods and applications in oncology. Annals of Oncology. 23(5). 1104–1110. 83 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melissa Accordino Breakdown of academic impact, for papers by Nina N. Sanford Breakdown of academic impact, for papers by Randa Sifri Breakdown of academic impact, for papers by Belinda E. Kiely Breakdown of academic impact, for papers by Clarissa Mathias Breakdown of academic impact, for papers by Corina van den Hurk Breakdown of academic impact, for papers by J. Bernhard Breakdown of academic impact, for papers by Jacobo Rogado Breakdown of academic impact, for papers by Natalie Fitzgerald Breakdown of academic impact, for papers by Inge R. Konings
Rankless by CCL
2026